LGALS9 and head and neck squamous cell carcinoma: Conversely, in certain settings such as head and neck squamous cell carcinoma (HNSCC), high TIM-3 expression correlates with enhanced NK cell cytotoxicity, and this enhancement can be counteracted by Galectin-9-mediated inhibition [20].